Literature DB >> 9729530

Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics.

H J de Haard1, B Kazemier, M J Koolen, L J Nijholt, R H Meloen, B van Gemen, H R Hoogenboom, J W Arends.   

Abstract

By application of combinatorial library technology, we generated the first recombinant antibody fragments directed against the major capsid protein p24 of human immunodeficiency virus type 1 (HIV-1). A library of single-chain Fv fragments (scFvs) was constructed by using the antibody variable-region (V) genes of B cells derived from the spleen of a viral lysate-immunized mouse. Antibodies were selected by panning or by enrichment with biotinylated antigen, yielding four different families of antibody fragments. The different types of scFvs were characterized by affinity measurements, by antigen recognition on Western blots, and by pepscan analysis. The epitope of one of the scFvs is located near the residues involved in CypA binding, thereby making it an attractive candidate for therapeutic applications. Comparison of the V gene sequence of this scFV with that of a previously described monoclonal antibody reactive against this immunodominant epitope revealed the usage of the identical combination of VH and Vkappa regions. Thus, this is one of the rare examples in which the original combination in a library-derived antibody fragment was retrieved. After appropriate affinity and format improvements, the best of our recombinant scFvs may form the basis for a sensitive p24 assay as a measure of viral load. In addition, anti-p24 scFvs could be expressed as intracellular antibodies (intrabodies) to aid in the treatment of HIV infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729530      PMCID: PMC95634          DOI: 10.1128/CDLI.5.5.636-644.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  66 in total

1.  The effect of epitope density and antibody affinity on the ELISA as analysed by monoclonal antibodies.

Authors:  A M Lew
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

2.  Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.

Authors:  H M Geysen; R H Meloen; S J Barteling
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

3.  Effects of bacteriophage f1 gene III protein on the host cell membrane.

Authors:  J D Boeke; P Model; N D Zinder
Journal:  Mol Gen Genet       Date:  1982

4.  Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.

Authors:  L S Ehrlich; B E Agresta; C A Carter
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

5.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Isolation and transmission of human retrovirus (human t-cell leukemia virus).

Authors:  M Popovic; P S Sarin; M Robert-Gurroff; V S Kalyanaraman; D Mann; J Minowada; R C Gallo
Journal:  Science       Date:  1983-02-18       Impact factor: 47.728

7.  By-passing immunization: building high affinity human antibodies by chain shuffling.

Authors:  J D Marks; A D Griffiths; M Malmqvist; T P Clackson; J M Bye; G Winter
Journal:  Biotechnology (N Y)       Date:  1992-07

8.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.

Authors:  A Billich; F Hammerschmid; P Peichl; R Wenger; G Zenke; V Quesniaux; B Rosenwirth
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies.

Authors:  A M Mhashilkar; J Bagley; S Y Chen; A M Szilvay; D G Helland; W A Marasco
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

View more
  5 in total

1.  Recombinant single-chain Fv antibodies that recognize the p25 protein of the Maedi-Visna virus.

Authors:  V Celer; D Blazek; I Navrátilová; P Skládal; B Blacklaws; R Bujdoso
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Demystified...recombinant antibodies.

Authors:  K A Smith; P N Nelson; P Warren; S J Astley; P G Murray; J Greenman
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 3.  The production and application of single-chain antibody fragments.

Authors:  D Blazek; V Celer
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

4.  Chimeric peptide beacons: a direct polypeptide analog of DNA molecular beacons.

Authors:  Kenneth J Oh; Kevin J Cash; Arica A Lubin; Kevin W Plaxco
Journal:  Chem Commun (Camb)       Date:  2007-12-14       Impact factor: 6.222

5.  A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition.

Authors:  David Lutje Hulsik; Ying-ying Liu; Nika M Strokappe; Simone Battella; Mohamed El Khattabi; Laura E McCoy; Charles Sabin; Andreas Hinz; Miriam Hock; Pauline Macheboeuf; Alexandre M J J Bonvin; Johannes P M Langedijk; David Davis; Anna Forsman Quigley; Marlén M I Aasa-Chapman; Michael S Seaman; Alejandra Ramos; Pascal Poignard; Adrien Favier; Jean-Pierre Simorre; Robin A Weiss; C Theo Verrips; Winfried Weissenhorn; Lucy Rutten
Journal:  PLoS Pathog       Date:  2013-03-07       Impact factor: 6.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.